Cargando…

Age-Associated Seroprevalence of Coronavirus Antibodies: Population-Based Serosurveys in 2013 and 2020, British Columbia, Canada

BACKGROUND: Older adults have been disproportionately affected during the SARS-CoV-2 pandemic, including higher risk of severe disease and long-COVID. Prior exposure to endemic human coronaviruses (HCoV) may modulate the response to SARS-CoV-2 infection and contribute to age-related observations. We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanunliong, Guadalein, Liu, Aaron C., Kaweski, Samantha, Irvine, Mike, Reyes, Romina C., Purych, Dale, Krajden, Mel, Morshed, Muhammad, Sekirov, Inna, Gantt, Soren, Skowronski, Danuta M., Jassem, Agatha N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984254/ https://www.ncbi.nlm.nih.gov/pubmed/35401521 http://dx.doi.org/10.3389/fimmu.2022.836449

Ejemplares similares

Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada
por: Skowronski, Danuta M., et al.
Publicado: (2022)

Population SARS-CoV-2 Seroprevalence Using Antenatal Serum Samples in British Columbia, Canada
por: McClymont, Elisabeth, et al.
Publicado: (2021)

A novel multiplex electrochemiluminescent immunoassay for detection and quantification of anti-SARS-CoV-2 IgG and anti-seasonal endemic human coronavirus IgG
por: Li, Fang Fang, et al.
Publicado: (2022)

Persistence of Anti-SARS-CoV-2 Antibodies in Long Term Care Residents Over Seven Months After Two COVID-19 Outbreaks
por: Tanunliong, Guadalein, et al.
Publicado: (2022)

Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada
por: Skowronski, Danuta M., et al.
Publicado: (2023)

The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada
por: Nikiforuk, Aidan M., et al.
Publicado: (2021)

Effectiveness of Latent TB Screening and Treatment in People Initiating Dialysis in British Columbia, Canada
por: Romanowski, Kamila, et al.
Publicado: (2020)

SARS-CoV-2 mRNA Vaccine Effectiveness in Health Care Workers by Dosing Interval and Time Since Vaccination: Test-Negative Design, British Columbia, Canada
por: El Adam, Shiraz, et al.
Publicado: (2022)

SARS-CoV-2 serology: Validation of high-throughput chemiluminescent immunoassay (CLIA) platforms and a field study in British Columbia
por: Sekirov, Inna, et al.
Publicado: (2021)

Serological survey following SARS-COV-2 outbreaks at long-term care facilities in metro Vancouver, British Columbia: Implications for outbreak management and infection control policies
por: Vijh, Rohit, et al.
Publicado: (2021)

Human Illness from Avian Influenza H7N3, British Columbia
por: Tweed, S. Aleina, et al.
Publicado: (2004)

Prenatal hepatitis C screening, diagnoses, and follow-up testing in British Columbia, 2008–2019
por: Pearce, Margo E., et al.
Publicado: (2020)

Seroprevalences of hepatitis B virus and hepatitis C virus among participants of an Asian health fair in the Lower Mainland, British Columbia
por: Ip, Stephen, et al.
Publicado: (2015)

Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada
por: Skowronski, Danuta M, et al.
Publicado: (2021)

1726. Characterization of humoral immune responses to COVID-19 vaccination in children in Canada: interim analysis from the Severe acute respiratory syndrome-related coronavirus 2 PRevalence In children and youNG adults in British Columbia (SPRING) Study
por: Gaultier, Gabrielle N, et al.
Publicado: (2023)

Comparative Single-Dose mRNA and ChAdOx1 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2, Including Variants of Concern: Test-Negative Design, British Columbia, Canada
por: Skowronski, Danuta M, et al.
Publicado: (2022)

Avian Influenza A(H7N9) Virus Infection in 2 Travelers Returning from China to Canada, January 2015
por: Skowronski, Danuta M., et al.
Publicado: (2016)

HCV co-infection in HIV positive population in British Columbia, Canada
por: Buxton, Jane A, et al.
Publicado: (2010)

Towards targeted screening for acute HIV infections in British Columbia
por: Steinberg, Malcolm, et al.
Publicado: (2011)

British Columbia’s Experience after Implementation of the Treponema pallidum Reverse Algorithm and PCR Detection, 2015 to 2020
por: Morshed, Muhammad, et al.
Publicado: (2022)

Treatment outcomes for isoniazid-resistant tuberculosis under program conditions in British Columbia, Canada
por: Romanowski, Kamila, et al.
Publicado: (2017)

Novel Avian Influenza H7N3 Strain Outbreak, British Columbia
por: Hirst, Martin, et al.
Publicado: (2004)

Uptake of SARS-CoV-2 vaccination among structurally-marginalized people who use drugs in Vancouver, Canada
por: Reddon, Hudson, et al.
Publicado: (2023)

Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999–2007
por: Galanis, Eleni, et al.
Publicado: (2010)

Rapid Increase in SARS-CoV-2 P.1 Lineage Leading to Codominance with B.1.1.7 Lineage, British Columbia, Canada, January–April 2021
por: Hogan, Catherine A., et al.
Publicado: (2021)

Canadian antenatal COVID-19 seroprevalence study; population mapping of the COVID-19 pandemic utilizing stored antenatal sera
por: A, Atkinson, et al.
Publicado: (2023)

West Nile Virus Range Expansion into British Columbia
por: Roth, David, et al.
Publicado: (2010)

1158. Immunogenicity of COVID-19 vaccine four-dose series in healthy community dwelling adults 50 years and above: interim analysis from the ‘PRospEctiVe EvaluatioN of immuniTy after COVID-19 vaccines’ (PREVENT-COVID) study
por: Gaultier, Gabrielle N, et al.
Publicado: (2023)

Influenza Classification Suite: An automated Galaxy workflow for rapid influenza sequence analysis
por: Eisler, Diane, et al.
Publicado: (2020)

Highlight: British Columbia
Publicado: (2005)

The impact of COVID-19 pandemic control measures on HCV treatment initiation in British Columbia, Canada
por: Janjua, Naveed, et al.
Publicado: (2022)

Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada
por: Skowronski, Danuta M, et al.
Publicado: (2022)

Targeting screening and social marketing to increase detection of acute HIV infection in men who have sex with men in Vancouver, British Columbia
por: Gilbert, Mark, et al.
Publicado: (2013)

Performance of Immunoglobulin G Serology on Finger Prick Capillary Dried Blood Spot Samples to Detect a SARS-CoV-2 Antibody Response
por: Nikiforuk, Aidan M., et al.
Publicado: (2022)

Erratum for Nikiforuk et al., “Performance of Immunoglobulin G Serology on Finger Prick Capillary Dried Blood Spot Samples to Detect a SARS-CoV-2 Antibody Response”
por: Nikiforuk, Aidan M., et al.
Publicado: (2022)

Simple approximation of sample size for precise estimates of SARS-CoV-2 infection from point-seroprevalence studies
por: Nikiforuk, A.M., et al.
Publicado: (2022)

Characterization of Clostridium difficile Strains in British Columbia, Canada: A Shift from NAP1 Majority (2008) to Novel Strain Types (2013) in One Region
por: Jassem, Agatha N., et al.
Publicado: (2016)

HIV and liver transplantation: The British Columbia experience, 2004 to 2013
por: Tan-Tam, Clara, et al.
Publicado: (2014)

1725 Surveillance for Borrelia burgdorferi in Ixodes Ticks and Mice in British Columbia
por: Morshed, Muhammad G., et al.
Publicado: (2014)

Social Contacts and Transmission of COVID-19 in British Columbia, Canada
por: Ringa, Notice, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nmr6v9se15m37naner221qs58e